BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19296252)

  • 1. [A clinical study on the degree of mesorectal tumor invasion in middle-low rectal cancer].
    Zhou YB; Zhuo HQ; Li LL; Lv L; Li YJ; Zhou J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):159-62. PubMed ID: 19296252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic analysis of middle and lower rectal cancer with different degrees of infiltration in mesorectum].
    Zhuo HQ; Zhou YB; Lü L; Zhou J; Yang WY; Li YJ
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):820-2. PubMed ID: 19595121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mesorectal metastasis of middle and lower rectal cancer].
    Wan J; Wu ZY; Du JL; Yao Y; Wang ZD; Lin HH; Luo XL; Zhang W
    Zhonghua Wai Ke Za Zhi; 2006 Jul; 44(13):894-6. PubMed ID: 17067480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depth of mesorectal invasion has prognostic significance in T3N0 low rectal cancer.
    Tokoro T; Okuno K; Hida J; Ishimaru E; Ueda K; Yoshifuji T
    Hepatogastroenterology; 2009; 56(89):124-7. PubMed ID: 19453042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision.
    Lee SH; Hernandez de Anda E; Finne CO; Madoff RD; Garcia-Aguilar J
    Dis Colon Rectum; 2005 Dec; 48(12):2249-57. PubMed ID: 16400512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer.
    Das P; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Hoff PM; Eng C; Wolff RA; Janjan NA; Delclos ME; Krishnan S; Levy LB; Ellis LM; Crane CH
    Am J Clin Oncol; 2006 Jun; 29(3):219-24. PubMed ID: 16755173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of risk factors associated with local recurrence after radical resection of rectal carcinoma].
    Cui J; Wang JP; Huang YH; Xiang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):322-5. PubMed ID: 18636351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
    Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Matrix metalloproteinase-2 expression and its correlation with mesorectal metastasis in middle and lower rectal cancer].
    Wan J; Wu ZY; Lin HH; Luo XL; Zhang W; Du JL; Yao Y; Wang ZD
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):136-8. PubMed ID: 16555154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D; Kyau-Ummen B; Halbfass HJ
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
    Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
    Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of mesorectal involvement on the outcome of patients with rectal cancer].
    Li L; Chen ZR; Zhang Y; Wang XD; Shu Y; Zhou ZG; Li K
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):295-7. PubMed ID: 16608099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinic study of lateral lymph node metastasis in advanced lower rectal cancer].
    Wu ZY; Wan J; Yao Y; Zhao G; Du JL; Yang J
    Zhonghua Wai Ke Za Zhi; 2008 Feb; 46(3):190-2. PubMed ID: 18683713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is total mesorectal excision always necessary for T1-T2 lower rectal cancer?
    Kobayashi H; Mochizuki H; Kato T; Mori T; Kameoka S; Shirouzu K; Saito Y; Watanabe M; Morita T; Hida J; Ueno M; Ono M; Yasuno M; Sugihara K
    Ann Surg Oncol; 2010 Apr; 17(4):973-80. PubMed ID: 19953330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
    Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
    J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is postoperative radiotherapy useful for the rectal carcinoma in the era of total mesorectal excision?
    Suh KW; Kim BW; Chun M; Lim HY
    Hepatogastroenterology; 2002; 49(44):399-403. PubMed ID: 11995460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphovascular invasion is a significant prognosticator in rectal cancer patients who receive preoperative chemoradiotherapy followed by total mesorectal excision.
    Lee JH; Jang HS; Kim JG; Cho HM; Shim BY; Oh ST; Yoon SC; Kim YS; Choi BO; Kim SH
    Ann Surg Oncol; 2012 Apr; 19(4):1213-21. PubMed ID: 21935746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of resection of stage IV rectal cancer with mesorectal excision.
    Law WL; Chu KW
    J Surg Oncol; 2006 Jun; 93(7):523-8. PubMed ID: 16705728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Total excision of the mesorectum in cancer of the lower and middle rectum. Oncological and functional results].
    Kneist W; Heintz A; Wolf HK; Junginger T
    Chirurg; 2003 Feb; 74(2):125-31. PubMed ID: 12599030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local recurrence following total mesorectal excision with double-stapling anastomosis for rectal cancers: analysis of risk factors.
    Law WL; Chu KW
    World J Surg; 2002 Oct; 26(10):1272-6. PubMed ID: 12205546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.